- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Titan Medical Inc. Announces Terms of Overnight Marketed Equity Offering
Titan Medical Inc. (TSX: TMD, OTCQX: TITXF) has priced its previously announced overnight marketed offering of equity securities.
Titan Medical Inc. (TSX: TMD, OTCQX: TITXF) has priced its previously announced overnight marketed offering of equity securities.
According to the company’s press release:
Pursuant to the Offering, Titan will issue an aggregate of up to 8,888,889 units of the Company (“Units”) at a price of C$0.90 per Unit (the “Offering Price”) for aggregate gross proceeds of approximately C$8,000,000. Each Unit is comprised of one common share of the Company (a “Common Share”) and one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant is exercisable at a price of C$1.00 and entitles the holder thereof to acquire one common share of the Company (a “Warrant Share”) for a period of 5 years following the closing of the Offering.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.